{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:26:51Z","timestamp":1786577211962,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54335-0","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:26:56Z","timestamp":1780410416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ZIF-8\/polydopamine nanocomposite functionalized with hyaluronic acid and folic acid for pH-responsive resveratrol delivery and apoptosis induction in colorectal cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Saba","family":"Seyedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Homayouni Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Neamati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Masoumian Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"10207","key":"54335_CR1","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M. & Wallace, M. B. Colorectal cancer. Lancet 394(10207), 1467\u20131480 (2019).","journal-title":"Lancet"},{"key":"54335_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26051988","author":"J Haynes","year":"2025","unstructured":"Haynes, J. & Manogaran, P. Mechanisms and strategies to overcome drug resistance in colorectal cancer. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms26051988 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"54335_CR3","doi-asserted-by":"crossref","unstructured":"Brar B, Ranjan K, Palria A, Kumar R, Ghosh M, Sihag S, et al. Nanotechnology in colorectal cancer for precision diagnosis and therapy. Front. Nanotechnol. 3 (2021).","DOI":"10.3389\/fnano.2021.699266"},{"issue":"12","key":"54335_CR4","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1039\/C7RA12969F","volume":"8","author":"F Shu","year":"2018","unstructured":"Shu, F. et al. Fabrication of a hyaluronic acid conjugated metal organic framework for targeted drug delivery and magnetic resonance imaging. RSC Adv. 8(12), 6581\u20136589 (2018).","journal-title":"RSC Adv."},{"key":"54335_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren, B. et al. Resveratrol for cancer therapy: Challenges and future perspectives. Cancer Lett. 515, 63\u201372 (2021).","journal-title":"Cancer Lett."},{"key":"54335_CR6","unstructured":"Cytion. HCT116 cell line: A comprehensive guide to colorectal cancer research. (2025)."},{"issue":"12","key":"54335_CR7","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1039\/D4TB02289K","volume":"13","author":"W Gao","year":"2025","unstructured":"Gao, W. et al. Functionalized ZIF-8 as a versatile platform for drug delivery and cancer therapy: Strategies, challenges and prospects. J. Mater. Chem. B 13(12), 3758\u20133785 (2025).","journal-title":"J. Mater. Chem. B"},{"issue":"8","key":"54335_CR8","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.3390\/cancers16081569","volume":"16","author":"P Ziranu","year":"2024","unstructured":"Ziranu, P. et al. CD44: A new prognostic marker in colorectal cancer?. Cancers 16(8), 1569 (2024).","journal-title":"Cancers"},{"issue":"1","key":"54335_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41419-018-1265-7","volume":"10","author":"L Ma","year":"2019","unstructured":"Ma, L., Dong, L. & Chang, P. CD44v6 engages in colorectal cancer progression. Cell Death Dis. 10(1), 30 (2019).","journal-title":"Cell Death Dis."},{"issue":"2","key":"54335_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s00432-025-06141-w","volume":"151","author":"D Kaidi","year":"2025","unstructured":"Kaidi, D., Odin, E., Wettergren, Y. & BexeLindskog, E. Prognostic value of folate-associated gene expression in stage II colon cancer. J. Cancer Res. Clin. Oncol. 151(2), 92 (2025).","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"54335_CR11","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1039\/D3TB02571C","volume":"12","author":"S Iranpour","year":"2024","unstructured":"Iranpour, S., Bahrami, A. R., Dayyani, M., Saljooghi, A. S. & Matin, M. M. A potent multifunctional ZIF-8 nanoplatform developed for colorectal cancer therapy by triple-delivery of chemo\/radio\/targeted therapy agents. J. Mater. Chem. B. 12(4), 1096\u20131114 (2024).","journal-title":"J. Mater. Chem. B."},{"key":"54335_CR12","doi-asserted-by":"crossref","unstructured":"Wang F, Jiang Y, Wang Y. Resveratrol-loaded metal-organic framework for mitochondria-targeted amplified CO gas therapy. Front. Chem. 13 (2025).","DOI":"10.3389\/fchem.2025.1545850"},{"issue":"7","key":"54335_CR13","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3390\/pharmaceutics15072014","volume":"15","author":"F Luo","year":"2023","unstructured":"Luo, F. et al. Dual-ligand synergistic targeting anti-tumor nanoplatforms with cascade-responsive drug release. Pharmaceutics 15(7), 2014 (2023).","journal-title":"Pharmaceutics"},{"key":"54335_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16040569","author":"M Salla","year":"2024","unstructured":"Salla, M. et al. Enhancing the bioavailability of resveratrol: Combine it, derivatize it, or encapsulate it?. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics16040569 (2024).","journal-title":"Pharmaceutics"},{"issue":"1","key":"54335_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-023-06508-7","volume":"16","author":"Z ShakibaySenobari","year":"2023","unstructured":"ShakibaySenobari, Z. et al. Chromone-embedded peptidomimetics and furopyrimidines as highly potent SARS-CoV-2 infection inhibitors: Docking and MD simulation study. BMC Res. Notes. 16(1), 224 (2023).","journal-title":"BMC Res. Notes."},{"issue":"1","key":"54335_CR16","doi-asserted-by":"publisher","DOI":"10.5812\/ijpr-144928","volume":"23","author":"M Ahmadi","year":"2024","unstructured":"Ahmadi, M. et al. Optimization of the synthesis and radiolabeling of ZIF-8 nanoparticles. Iran. J. Pharm. Res. 23(1), e144928 (2024).","journal-title":"Iran. J. Pharm. Res."},{"issue":"8","key":"54335_CR17","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1039\/D2TB02361J","volume":"11","author":"Q Wang","year":"2023","unstructured":"Wang, Q. et al. ZIF-8 integrated with polydopamine coating as a novel nano-platform for skin-specific drug delivery. Journal of Materials Chemistry B. 11(8), 1782\u20131797 (2023).","journal-title":"Journal of Materials Chemistry B."},{"issue":"9","key":"54335_CR18","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1021\/acs.molpharmaceut.8b00473","volume":"15","author":"Q Li","year":"2018","unstructured":"Li, Q. et al. Hyaluronic acid\u2013Methotrexate conjugates coated magnetic polydopamine nanoparticles for multimodal imaging-guided multistage targeted chemo-photothermal therapy. Mol. Pharm. 15(9), 4049\u20134062 (2018).","journal-title":"Mol. Pharm."},{"issue":"3","key":"54335_CR19","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1007\/s00210-023-02707-y","volume":"397","author":"MA Oryani","year":"2024","unstructured":"Oryani, M. A. et al. Targeted cancer treatment using folate-conjugated sponge-like ZIF-8 nanoparticles: A review. Naunyn Schmiedebergs Arch. Pharmacol. 397(3), 1377\u20131404 (2024).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"2","key":"54335_CR20","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.toxlet.2005.07.001","volume":"160","author":"G Fotakis","year":"2006","unstructured":"Fotakis, G. & Timbrell, J. A. In vitro cytotoxicity assays: Comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol. Lett. 160(2), 171\u2013177 (2006).","journal-title":"Toxicol. Lett."},{"key":"54335_CR21","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.2147\/IJN.S394694","volume":"18","author":"X Luo","year":"2023","unstructured":"Luo, X., Xie, D., Su, J. & Hu, J. Inflammatory genes associated with pristine multi-walled carbon nanotubes-induced toxicity in ocular cells. Int. J. Nanomedicine 18, 2465\u20132484 (2023).","journal-title":"Int. J. Nanomedicine"},{"issue":"4","key":"54335_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4), 402\u2013408 (2001).","journal-title":"Methods"},{"key":"54335_CR23","first-page":"23","volume":"294","author":"LG Rodriguez","year":"2005","unstructured":"Rodriguez, L. G., Wu, X. & Guan, J. L. Wound-healing assay. Methods Mol. Biol. 294, 23\u201329 (2005).","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"54335_CR24","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/biom14050544","volume":"14","author":"A Tondar","year":"2024","unstructured":"Tondar, A. et al. Virtual screening of small molecules targeting BCL2 with machine learning, molecular docking, and MD simulation. Biomolecules 14(5), 544 (2024).","journal-title":"Biomolecules"},{"issue":"8","key":"54335_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-021-01513-x","volume":"38","author":"X Lv","year":"2021","unstructured":"Lv, X. et al. Computational study on novel natural inhibitors targeting BCL2. Med. Oncol. 38(8), 94 (2021).","journal-title":"Med. Oncol."},{"key":"54335_CR26","doi-asserted-by":"crossref","unstructured":"Liu T-h, Tu W-q, Tao W-c, Liang Q-e, Xiao Y, Chen L-g. Verification of resveratrol inhibits intestinal aging by downregulating ATF4\/Chop\/Bcl-2\/Bax signaling pathway: based on network pharmacology and animal experiment. Front. Pharmacol. 11 (2020).","DOI":"10.3389\/fphar.2020.01064"},{"issue":"1","key":"54335_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-65509-1","volume":"16","author":"L Maillet","year":"2025","unstructured":"Maillet, L. et al. Allosteric regulation of BH3-in-groove interactions by tail anchors of BCL-xL complexes limits BH3 mimetic antagonism. Nat. Commun. 16(1), 10621 (2025).","journal-title":"Nat. Commun."},{"issue":"8","key":"54335_CR28","doi-asserted-by":"publisher","first-page":"3777","DOI":"10.1007\/s00018-021-03771-4","volume":"78","author":"S Dadsena","year":"2021","unstructured":"Dadsena, S., Jenner, A. & Garc\u00eda-S\u00e1ez, A. J. Mitochondrial outer membrane permeabilization at the single molecule level. Cell. Mol. Life Sci. 78(8), 3777\u20133790 (2021).","journal-title":"Cell. Mol. Life Sci."},{"issue":"3","key":"54335_CR29","doi-asserted-by":"publisher","first-page":"362a","DOI":"10.1016\/j.bpj.2024.11.1966","volume":"124","author":"H Alimohamadi","year":"2025","unstructured":"Alimohamadi, H. et al. BPS2025 - Antagonistic curvature mechanisms of BCL-2 family proteins regulate mitochondrial apoptosis. Biophys. J . 124(3), 362a (2025).","journal-title":"Biophys. J ."},{"key":"54335_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14163935","author":"H Xie","year":"2022","unstructured":"Xie, H. et al. Nanoscale zeolitic imidazolate framework (ZIF)-8 in cancer theranostics: Current challenges and prospects. Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers14163935 (2022).","journal-title":"Cancers (Basel)"},{"issue":"2","key":"54335_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11705-020-1927-8","volume":"15","author":"S Feng","year":"2021","unstructured":"Feng, S., Zhang, X., Shi, D. & Wang, Z. Zeolitic imidazolate framework-8 (ZIF-8) for drug delivery: A critical review. Front. Chem. Sci. Eng. 15(2), 221\u2013237 (2021).","journal-title":"Front. Chem. Sci. Eng."},{"issue":"1","key":"54335_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/ph17010126","volume":"17","author":"M Ali","year":"2024","unstructured":"Ali, M. et al. Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent. Pharmaceuticals. 17(1), 126 (2024).","journal-title":"Pharmaceuticals."},{"key":"54335_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2019.00225","volume":"7","author":"Z Chaudhary","year":"2019","unstructured":"Chaudhary, Z. et al. Encapsulation and controlled release of resveratrol within functionalized mesoporous silica nanoparticles for prostate cancer therapy. Front. Bioeng. Biotechnol. 7, 225 (2019).","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"42","key":"54335_CR34","doi-asserted-by":"publisher","first-page":"17745","DOI":"10.1039\/C5NR04831A","volume":"7","author":"B Xiao","year":"2015","unstructured":"Xiao, B. et al. Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy. Nanoscale 7(42), 17745\u201317755 (2015).","journal-title":"Nanoscale"},{"issue":"13","key":"54335_CR35","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1039\/D4NA01015A","volume":"7","author":"TV Tran","year":"2025","unstructured":"Tran, T. V. et al. Synthesis methods, structure, and recent trends of ZIF-8-based materials in the biomedical field. Nanoscale Advances. 7(13), 3941\u20133960 (2025).","journal-title":"Nanoscale Advances."},{"key":"54335_CR36","doi-asserted-by":"crossref","unstructured":"Brockmueller A, Buhrmann C, Shayan P, Shakibaei M. Resveratrol induces apoptosis by modulating the reciprocal crosstalk between p53 and Sirt-1 in the CRC tumor microenvironment. Front. Immunol. 14 (2023).","DOI":"10.3389\/fimmu.2023.1225530"},{"issue":"1","key":"54335_CR37","doi-asserted-by":"publisher","first-page":"22358","DOI":"10.1038\/s41598-023-49171-5","volume":"13","author":"E Sadri","year":"2023","unstructured":"Sadri, E. et al. Enhanced anti-tumor activity of transferrin\/folate dual-targeting magnetic nanoparticles using chemo-thermo therapy on retinoblastoma cancer cells Y79. Sci Rep. 13(1), 22358 (2023).","journal-title":"Sci Rep."},{"issue":"20","key":"54335_CR38","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1038\/onc.2014.194","volume":"34","author":"N Oi","year":"2015","unstructured":"Oi, N. et al. Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1. Oncogene 34(20), 2660\u20132671 (2015).","journal-title":"Oncogene"},{"issue":"8","key":"54335_CR39","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10495-008-0235-4","volume":"13","author":"PM Brito","year":"2008","unstructured":"Brito, P. M., Sim\u00f5es, N. F., Almeida, L. M. & Dinis, T. C. Resveratrol disrupts peroxynitrite-triggered mitochondrial apoptotic pathway: A role for Bcl-2. Apoptosis 13(8), 1043\u20131053 (2008).","journal-title":"Apoptosis"},{"issue":"1","key":"54335_CR40","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12935-022-02801-w","volume":"22","author":"P Bouchalova","year":"2022","unstructured":"Bouchalova, P. & Bouchal, P. Current methods for studying metastatic potential of tumor cells. Cancer Cell Int. 22(1), 394 (2022).","journal-title":"Cancer Cell Int."},{"issue":"4","key":"54335_CR41","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3390\/pharmaceutics17040479","volume":"17","author":"X Li","year":"2025","unstructured":"Li, X. & Xu, Z. Applications of Matrix Metalloproteinase-9-related nanomedicines in tumors and vascular diseases. Pharmaceutics 17(4), 479 (2025).","journal-title":"Pharmaceutics"},{"issue":"1","key":"54335_CR42","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s12672-025-02929-x","volume":"16","author":"A Baghbanzadeh","year":"2025","unstructured":"Baghbanzadeh, A. et al. miR-146a-5p suppresses migration and downregulates vimentin and MMP-9 expression in gastric cancer cells. Discov. Oncol. 16(1), 1075 (2025).","journal-title":"Discov. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54335-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54335-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T22:31:42Z","timestamp":1786573902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54335-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54335"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54335-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with all relevant institutional and national policies governing the care and use of laboratory animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25146"}}